The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global General Anesthesia Drugs Market Research Report 2025

Global General Anesthesia Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1735289

No of Pages : 89

Ask Your Query

Report Description
Table of Content

Synopsis

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.

The global General Anesthesia Drugs market was valued at US$ 3925.7 million in 2023 and is anticipated to reach US$ 4982.9 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.

Global key players of general anesthesia drugs include Fresenius-Kabi, Baxter Healthcare, Aspen Pharma, etc. The top three players hold a share about 37%. Americas is the largest market, has a share about 36%, followed by Asia-Pacific and Europe, with share 29% and 28%, separately.

This report aims to provide a comprehensive presentation of the global market for General Anesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anesthesia Drugs.

Report Scope

The General Anesthesia Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global General Anesthesia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the General Anesthesia Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang

Segment by Type

Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Others

Segment by Application

Intravenous Anesthetics
Inhalational Anesthetics

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of General Anesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 General Anesthesia Drugs Market Overview
1.1 Product Overview and Scope of General Anesthesia Drugs
1.2 General Anesthesia Drugs Segment by Type
1.2.1 Global General Anesthesia Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Remifentanil
1.2.5 Etomidate
1.2.6 Isoflurane
1.2.7 Others
1.3 General Anesthesia Drugs Segment by Application
1.3.1 Global General Anesthesia Drugs Market Value by Application: (2024-2030)
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Global General Anesthesia Drugs Market Size Estimates and Forecasts
1.4.1 Global General Anesthesia Drugs Revenue 2019-2030
1.4.2 Global General Anesthesia Drugs Sales 2019-2030
1.4.3 Global General Anesthesia Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 General Anesthesia Drugs Market Competition by Manufacturers
2.1 Global General Anesthesia Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global General Anesthesia Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global General Anesthesia Drugs Average Price by Manufacturers (2019-2024)
2.4 Global General Anesthesia Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of General Anesthesia Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of General Anesthesia Drugs, Product Type & Application
2.7 General Anesthesia Drugs Market Competitive Situation and Trends
2.7.1 General Anesthesia Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest General Anesthesia Drugs Players Market Share by Revenue
2.7.3 Global General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 General Anesthesia Drugs Retrospective Market Scenario by Region
3.1 Global General Anesthesia Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global General Anesthesia Drugs Global General Anesthesia Drugs Sales by Region: 2019-2030
3.2.1 Global General Anesthesia Drugs Sales by Region: 2019-2024
3.2.2 Global General Anesthesia Drugs Sales by Region: 2025-2030
3.3 Global General Anesthesia Drugs Global General Anesthesia Drugs Revenue by Region: 2019-2030
3.3.1 Global General Anesthesia Drugs Revenue by Region: 2019-2024
3.3.2 Global General Anesthesia Drugs Revenue by Region: 2025-2030
3.4 North America General Anesthesia Drugs Market Facts & Figures by Country
3.4.1 North America General Anesthesia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America General Anesthesia Drugs Sales by Country (2019-2030)
3.4.3 North America General Anesthesia Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe General Anesthesia Drugs Market Facts & Figures by Country
3.5.1 Europe General Anesthesia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe General Anesthesia Drugs Sales by Country (2019-2030)
3.5.3 Europe General Anesthesia Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific General Anesthesia Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific General Anesthesia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific General Anesthesia Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific General Anesthesia Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America General Anesthesia Drugs Market Facts & Figures by Country
3.7.1 Latin America General Anesthesia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America General Anesthesia Drugs Sales by Country (2019-2030)
3.7.3 Latin America General Anesthesia Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa General Anesthesia Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa General Anesthesia Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa General Anesthesia Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa General Anesthesia Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global General Anesthesia Drugs Sales by Type (2019-2030)
4.1.1 Global General Anesthesia Drugs Sales by Type (2019-2024)
4.1.2 Global General Anesthesia Drugs Sales by Type (2025-2030)
4.1.3 Global General Anesthesia Drugs Sales Market Share by Type (2019-2030)
4.2 Global General Anesthesia Drugs Revenue by Type (2019-2030)
4.2.1 Global General Anesthesia Drugs Revenue by Type (2019-2024)
4.2.2 Global General Anesthesia Drugs Revenue by Type (2025-2030)
4.2.3 Global General Anesthesia Drugs Revenue Market Share by Type (2019-2030)
4.3 Global General Anesthesia Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global General Anesthesia Drugs Sales by Application (2019-2030)
5.1.1 Global General Anesthesia Drugs Sales by Application (2019-2024)
5.1.2 Global General Anesthesia Drugs Sales by Application (2025-2030)
5.1.3 Global General Anesthesia Drugs Sales Market Share by Application (2019-2030)
5.2 Global General Anesthesia Drugs Revenue by Application (2019-2030)
5.2.1 Global General Anesthesia Drugs Revenue by Application (2019-2024)
5.2.2 Global General Anesthesia Drugs Revenue by Application (2025-2030)
5.2.3 Global General Anesthesia Drugs Revenue Market Share by Application (2019-2030)
5.3 Global General Anesthesia Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Aspen Pharma
6.1.1 Aspen Pharma Corporation Information
6.1.2 Aspen Pharma Description and Business Overview
6.1.3 Aspen Pharma General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Aspen Pharma General Anesthesia Drugs Product Portfolio
6.1.5 Aspen Pharma Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Corporation Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fresenius-Kabi General Anesthesia Drugs Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AbbVie General Anesthesia Drugs Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Corporation Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter Healthcare General Anesthesia Drugs Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 B.Braun
6.5.1 B.Braun Corporation Information
6.5.2 B.Braun Description and Business Overview
6.5.3 B.Braun General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B.Braun General Anesthesia Drugs Product Portfolio
6.5.5 B.Braun Recent Developments/Updates
6.6 Maruishi
6.6.1 Maruishi Corporation Information
6.6.2 Maruishi Description and Business Overview
6.6.3 Maruishi General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Maruishi General Anesthesia Drugs Product Portfolio
6.6.5 Maruishi Recent Developments/Updates
6.7 Piramal
6.6.1 Piramal Corporation Information
6.6.2 Piramal Description and Business Overview
6.6.3 Piramal General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Piramal General Anesthesia Drugs Product Portfolio
6.7.5 Piramal Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Corporation Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Yichang Humanwell
6.9.1 Yichang Humanwell Corporation Information
6.9.2 Yichang Humanwell Description and Business Overview
6.9.3 Yichang Humanwell General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Yichang Humanwell General Anesthesia Drugs Product Portfolio
6.9.5 Yichang Humanwell Recent Developments/Updates
6.10 Nhwa
6.10.1 Nhwa Corporation Information
6.10.2 Nhwa Description and Business Overview
6.10.3 Nhwa General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nhwa General Anesthesia Drugs Product Portfolio
6.10.5 Nhwa Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Corporation Information
6.11.2 Hengrui General Anesthesia Drugs Description and Business Overview
6.11.3 Hengrui General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hengrui General Anesthesia Drugs Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Xi'an Libang
6.12.1 Xi'an Libang Corporation Information
6.12.2 Xi'an Libang General Anesthesia Drugs Description and Business Overview
6.12.3 Xi'an Libang General Anesthesia Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Xi'an Libang General Anesthesia Drugs Product Portfolio
6.12.5 Xi'an Libang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 General Anesthesia Drugs Industry Chain Analysis
7.2 General Anesthesia Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 General Anesthesia Drugs Production Mode & Process
7.4 General Anesthesia Drugs Sales and Marketing
7.4.1 General Anesthesia Drugs Sales Channels
7.4.2 General Anesthesia Drugs Distributors
7.5 General Anesthesia Drugs Customers
8 General Anesthesia Drugs Market Dynamics
8.1 General Anesthesia Drugs Industry Trends
8.2 General Anesthesia Drugs Market Drivers
8.3 General Anesthesia Drugs Market Challenges
8.4 General Anesthesia Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}